JP2007507514A5 - - Google Patents

Download PDF

Info

Publication number
JP2007507514A5
JP2007507514A5 JP2006534060A JP2006534060A JP2007507514A5 JP 2007507514 A5 JP2007507514 A5 JP 2007507514A5 JP 2006534060 A JP2006534060 A JP 2006534060A JP 2006534060 A JP2006534060 A JP 2006534060A JP 2007507514 A5 JP2007507514 A5 JP 2007507514A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
members
substituent assignments
independent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006534060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007507514A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/032003 external-priority patent/WO2005033088A1/en
Publication of JP2007507514A publication Critical patent/JP2007507514A/ja
Publication of JP2007507514A5 publication Critical patent/JP2007507514A5/ja
Pending legal-status Critical Current

Links

JP2006534060A 2003-09-30 2004-09-29 キノキサリン化合物 Pending JP2007507514A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50717603P 2003-09-30 2003-09-30
PCT/US2004/032003 WO2005033088A1 (en) 2003-09-30 2004-09-29 Quinoxaline compounds

Publications (2)

Publication Number Publication Date
JP2007507514A JP2007507514A (ja) 2007-03-29
JP2007507514A5 true JP2007507514A5 (2) 2007-11-22

Family

ID=34421591

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006534060A Pending JP2007507514A (ja) 2003-09-30 2004-09-29 キノキサリン化合物

Country Status (11)

Country Link
US (1) US20050070527A1 (2)
EP (1) EP1670774A1 (2)
JP (1) JP2007507514A (2)
KR (1) KR20060111466A (2)
CN (1) CN1886389B (2)
AU (2) AU2004278372B2 (2)
CA (1) CA2540638A1 (2)
IL (1) IL174629A0 (2)
MX (1) MXPA06003578A (2)
WO (1) WO2005033088A1 (2)
ZA (1) ZA200603410B (2)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
PL2007752T3 (pl) 2006-03-31 2011-02-28 Janssen Pharmaceutica Nv Benzoimidazol-2-ilopirymidyny i pirazyny jako modulatory receptora histaminowego H4
WO2007120690A2 (en) * 2006-04-10 2007-10-25 Janssen Pharmaceutica N.V. Combination histamine h1r and h4r antagonist therapy for treating pruritus
AU2007271187A1 (en) * 2006-07-03 2008-01-10 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Fused bicyclic compounds interacting with the histamine H4 receptor
GB0614471D0 (en) 2006-07-20 2006-08-30 Syngenta Ltd Herbicidal Compounds
US7985745B2 (en) 2006-10-02 2011-07-26 Abbott Laboratories Method for pain treatment
EP2077263A1 (en) 2008-01-02 2009-07-08 Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg Quinazolines and related heterocyclic compounds and their therapeutic use
MX2010013727A (es) * 2008-06-12 2011-01-14 Janssen Pharmaceutica Nv Uso de un antagonista h4 de histamina para el tratamiento de adherencias postoperatorias.
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
EP2201982A1 (en) 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP2013518085A (ja) 2010-02-01 2013-05-20 ノバルティス アーゲー CRF−1受容体アンタゴニストとしてのピラゾロ[5,1b]オキサゾール誘導体
JP5748777B2 (ja) 2010-02-02 2015-07-15 ノバルティス アーゲー Crf受容体アンタゴニストとしてのシクロヘキシルアミド誘導体
UY34094A (es) 2011-05-27 2013-01-03 Novartis Ag Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
CA2867043A1 (en) 2012-05-03 2013-11-07 Novartis Ag L-malate salt of 2,7-diaza-spiro[4.5]dec-7-yle derivatives and crystalline forms thereof as ghrelin receptor agonists
HUE039713T2 (hu) 2012-06-08 2019-02-28 Sensorion H4 receptor inhibitorok tinnitus kezelésére
SMT202000084T1 (it) 2013-03-06 2020-03-13 Janssen Pharmaceutica Nv Modulatori benzoimidazol-2-il pirimidinici del recettore h4 dell'istamina
CN105001169B (zh) * 2015-07-09 2017-07-21 华侨大学 一种3‑氨基喹喔啉‑2(1h)‑酮类化合物的合成方法
CN110092760B (zh) * 2019-06-04 2020-11-13 杭州师范大学 一种3-氟代烷氧基-2(1h)-喹喔啉酮及其合成方法
WO2023002011A1 (en) * 2021-07-23 2023-01-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Gram-negative bacteria efflux pump inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493572A (en) * 1968-07-05 1970-02-03 Pfizer & Co C Process for producing quinoxaline-di-n-oxides
FI193974A7 (2) * 1973-07-13 1975-01-14 Merck & Co Inc
EP0008864A1 (en) * 1978-08-15 1980-03-19 FISONS plc Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DE4342024A1 (de) * 1993-12-09 1995-06-14 Hoechst Ag Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid
MY132385A (en) * 1995-08-31 2007-10-31 Novartis Ag 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
PT1534391E (pt) * 2002-07-19 2007-05-31 Biovitrum Ab Novos derivados e piperazinilo-pirazinona para o tratamento de desordens relacionadas com o receptor 5-ht

Similar Documents

Publication Publication Date Title
JP2007507514A5 (2)
US11919896B2 (en) [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof
CN1129581C (zh) 氰基苯基衍生物
DE69110320T2 (de) Stickstoff enthaltende heterozyklische Verbindungen, ihre Herstellung und Verwendung.
JP4853965B2 (ja) アダマンタン誘導体およびアザビシクロオクタン誘導体およびアザビシクロノナン誘導体、ならびにこれらの調製方法およびdpp−iv阻害剤としてのこれらの使用
CA2657702A1 (en) Quinazolines and related heterocyclic comp0unds, and their therapeutic use
JPS61152662A (ja) 新規な二環式複素アリールピペラジン化合物とその医薬並びにその製造法
RU2009113585A (ru) Производные дибензофурана в качестве ингибиторов pde-4 и pde-10
HRP20041005A2 (en) Quinoline and isoquinoline derivatives, method forthe production thereof and use thereof as anti-inflammatory agents
KR20160111999A (ko) 소포성 모노아민 수송체 2의 벤조퀴놀린 억제제
WO2006125180B1 (en) Piperazine derivatives and their uses as therapeutic agents
ME02672B (me) Fenil-3-aza-bicikl0[3.1.0]heks-3-il-metanoni i njihova primena kao medikament
MX2009000110A (es) Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor grp38.
ZA200604395B (en) Novel M3 Muscarinic Acetylcholine receptor antagonists
JP2007524706A (ja) ピペリジニルアルキルカーバメートの誘導体、これらの製造方法及びfaah酵素インヒビターとしての使用
EP2305652A2 (en) Trisubstituted quinazolinone derivatives as vanilloid antagonists
JP2014504648A5 (2)
JPH04182467A (ja) ジアリールメトキシピペリジン誘導体
JP7618642B2 (ja) インターロイキンの調節におけるプロドラッグ
JP2020517676A5 (2)
JPS58159480A (ja) 新規なフエニルピペラジン誘導体
JP2823620B2 (ja) 2−ヒドロキシ−3−フェノキシ−プロピル−置換ピペラジンないしはホモピペラジン
RU2015114405A (ru) Замещенные соединения фенилкарбамата
JPS5840552B2 (ja) 1,4− ベンゾジオキサンノ アミンユウドウタイノセイホウ
JP2008538762A (ja) 新規ムスカリン受容体アンタゴニスト